HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intestinal mucinous substances in gastric intestinal metaplasia and carcinoma studied by immunofluorescence.

Abstract
Immunofluorescent studies using specific antisera against intestinal mucins revealed small intestinal mucin antigen (SIMA) and large intestinal mucin antigen (LIMA) in areas of intestinal metaplasia of the stomach. In 25 gastric carcinomas studied, both these antigens were detected in seven carcinomas, SIMA only was present in four and LIMA in only four cases; the antigens could not be detected in ten of the carcinomas. In 21 of the 25 gastric operation specimens, including the 15 carcinomas positive for intestinal mucin antigens, there was evidence of chronic gastritis and intestinal metaplasia. These immunohistologic observations confirm the results of recent histochemical studies that both small and large intestinal type mucins are present in intestinal metaplasia and gastric carcinomas. Our findings provide further evidence that at least a proportion of gastric carcinomas may supervene on intestinal metaplasia. The absence of one or both antigens in gastric carcinomas may indicate stages of dedifferentiation or alternatively differences in histogenesis.
AuthorsJ Ma, W G De Boer, J Nayman
JournalCancer (Cancer) Vol. 49 Issue 8 Pg. 1664-7 (Apr 15 1982) ISSN: 0008-543X [Print] United States
PMID6279272 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens
  • Mucins
Topics
  • Adenocarcinoma, Mucinous (immunology, metabolism)
  • Adult
  • Antigens (analysis)
  • Female
  • Fetal Diseases (immunology)
  • Fluorescent Antibody Technique
  • Gastric Mucosa (pathology)
  • Gastrointestinal Neoplasms (immunology, metabolism)
  • Gestational Age
  • Humans
  • Intestine, Large (pathology)
  • Intestine, Small (pathology)
  • Metaplasia (immunology, metabolism)
  • Mucins (analysis, immunology)
  • Pregnancy
  • Stomach (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: